EPElena N. Plakhotina

Elena N. Plakhotina

*This is an algorithmically generated author record based on publicly available information.

Elena N. Plakhotina has a total of 91 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Catamnesis of patients who underwent surgical treatment of placental regrowth in the Russian Federation (pilot multicenter study)

    by R.G. Shmakov, M.A. Kurtser, V.D. Chuprynin, T.A. Yarygina, T.M. Zabelina, S.V. Barinov, T.N. Belousova, E.N. Plakhotina, E.R. Milyutina, Ya.I. Adamov, et al.

    The aim of the study was to analyze the catamnesis of patients who underwent surgical treatment of placenta accreta in specialized perinatal centers in the Russian Federation. Materials and methods. A retrospective multicenter study, analysis of clinical and anamnestic data, gynecological and obstetric catamnesis of 2.652 patients who underwent surgical treatment for placenta accreta in 2014—2024 in 31 regions of the Russian Federation, as well as V.I. Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology, Moscow, Russian Federation, V.I. Krasnopolsky Moscow Regional Research Institute of Obstetrics and Gynecology, Moscow, Russia and hospitals of the Mother and Child Group of Companies. Results. Among the total cohort of 2652 patients, 229 (8.6%) patients underwent hysterectomy during surgical treatment of placenta accreta, 2423 (91.4%) patients underwent organ-preserving surgery, of which 609 (23%) underwent surgical sterilization. Hysterectomy compared with metroplasty was accompanied by a significantly greater blood loss of 2403 (1974—2850) versus 1693 (1105—23 75) ml (p<0.001), a higher incidence of intraoperative complications such as massive blood loss of more than 2500 ml (30.56% (n=70) versus 6.93%, (n=168), (p<0.001) and bladder resection (31.88% (n=73) vs. 2.23% (n=54), (p<0.001). In 2018 (83.28%) patients with organ-preserving surgery, the regular menstrual cycle was restored 4 (1—18) months after the operation. Menstrual cycle disorders and/or a symptomatic niche of the postoperative scar were noted in 55 (2.27%) cases. Clinical and laboratory manifestations of premature menopause were not observed in any case. Among 229 patients who underwent hysterectomy, 17 (7.42%) cases showed symptoms of premature menopause. The frequency of urinary problems did not differ significantly between the groups, amounting to 116 (4.78%) versus 15 (6.55%) cases (p=0.242), in metroplasty and hysterectomy, respectively. According to the PISQ questionnaire, sexual satisfaction was statistically higher in the group with organ-preserving surgery — 5 points, compared with organ-bearing surgery — 3 points (p=0.031). When analyzing the quality of life and health based on the Short Form 6 Dimensions SF-6D questionnaire in women with metroplasty, the median score was significantly higher than in patients with a removed uterus: 4 (3—5) versus 3 (1—4) of the maximum 5, respectively (p=0.031). Of the 1.814 patients with preserved reproductive function, subsequent pregnancies were observed in 7.88% (n=143), 88.11% (n=126) of which ended in delivery. The frequency of timely delivery was significantly higher than that of preterm delivery: 83.33% (n=105) cases versus 16.67% (n=21) (p<0.001). Among all deliveries, the median volume of intraoperative blood loss was 880 ml. Placenta accreta was diagnosed in 7.1% (n=9) of the cases, in one of which (0.79%, 1/126) it was complicated by massive blood loss, which caused a hysterectomy. Postpartum bleeding occurred in 3 (2.38%) patients. Neonatal outcomes did not differ from the population data. An analysis of blood flow reduction methods in the previous surgical treatment of placenta accreta demonstrated a significant correlation between the use of complex compression hemostasis with the possibility of organ-preserving surgery and the uncomplicated course of subsequent pregnancy. Conclusion. The results of the second stage of a multicenter nationwide study demonstrated that organ-preserving surgery for placenta accreta is associated with fewer intra– and postoperative complications, improved quality of life in patients and the possibility of further realization of their reproductive function.

  • Open Access

    Potential of Therapeutic Apheresis for Prolongation of Pregnancy in Early-Onset Preeclampsia

    by E. N. Plakhotina, T. N. Belousova, E. V. Bryantsev, N. V. Nizyaeva, K. A. Artemieva, A. A. Akhmetshina

    Preeclampsia with onset between 20 and 34 weeks is conditioned by the development of endothelial dysfunction caused by increased secretion of antiangiogenic factors, activation of the immune system, and the synthesis of inflammatory mediators. This complication is responsible for the progression of multiple organ failure in the mother, and more than 60,000 maternal deaths annually worldwide. The only method of therapy at present is early delivery. Such tactics lead to high neonatal morbidity and mortality.AIM OF STUDY To evaluate the possibilities of safely prolonging pregnancy using therapeutic apheresis methods in the development of early-onset preeclampsia.MATERIAL AND METHODS A prospective randomized study was conducted involving 58 patients diagnosed with early-onset severe preeclampsia. The patients were divided into three groups. The patients of the first group underwent 2 sessions of cascade plasma filtration with a total processed plasma volume of 4810 (3250; 5680) ml. In the second group, hemoperfusion was performed with a perfusion volume of 18,460 (16.890; 21.350) ml in two sessions. At the stages of the study, the dynamics of clinical and laboratory parameters of the mother and newborn were assessed in comparison with the control group.The use of cascade plasma filtration statistically significantly reduced the sFlt-1/PIGF ratio (p=0.017), pregnancy was prolonged by 32.5 (5.5; 42.5) days, the gestational age at delivery was 34.1 (29.6; 36.0) weeks. When using hemoperfusion, the level of neutrophil extracellular traps decreased statistically significantly. Pregnancy was prolonged by 26.5 (8; 52) days, the patients gave birth at a gestational age of 34.3 (33.5; 36.8) weeks. In the control group, the duration of pregnancy prolongation was 5.5 (2;7) days, pCONCLUSION The use of therapeutic apheresis techniques in patients with early-onset preeclampsia may allow for safe prolongation of pregnancy in the interests of the fetus, which requires further study.

  • Open Access

    Pontine stroke in a female patient with HELLP syndrome: description of a clinical case with a literature review

    by E. N. Plakhotina, T. N. Belousova, O. V. Chaplygina

    Introduction. The prevalence of HELLP syndrome ranges from 0.5% to 0.9%. The mortality rate during its development reaches 24%. One of the reasons for the unfavorable outcome of this complication is acute cerebrovascular accident, but the true frequency of this complication in HELLP syndrome is currently not specified. An even rarer complication is ischemic brainstem stroke. Progressive endothelial dysfunction leading to generalized microthrombosis and coagulopathy may be the cause of neurological complications in both HELLP syndrome and other types of thrombotic microangiopathy. Despite the fact that ischemic stroke is not an indication for therapeutic apheresis procedures, probably, their early onset with the development of stroke against the background of any of the options for obstetric thrombotic microangiopathy allows to gain time for a differential diagnosis and in a short time to improve the neurological status, laboratory parameters and general condition of the patient. The objective was to present a clinical case of the development of brainstem stroke in a patient with an atypical course of HELLP syndrome without clinical and laboratory signs of liver failure, to summarize existing data on the frequency of strokes during pregnancy, risk factors, etiology, as well as diagnostic and treatment strategies. Conclusion. Obstetric thrombotic microangiopathy can be the cause of ischemic stroke; it requires an urgent differential diagnosis with hemorrhagic stroke, thrombotic thrombocytopenic purpura, atypical hemolytic uremic syndrome and catastrophic antiphospholipid syndrome, an interdisciplinary approach to diagnosis and treatment, as well as early inclusion in the complex therapy of therapeutic apheresis.

  • Open Access

    Therapeutic Apheresis in Early-Onset Preeclampsia: Literature Review

    by Elena N. Plakhotina, Tamara N. Belousova, Evgenii V. Bryancev, Oksana V. Chaplygina

    Preeclampsia is a multisystem disorder that manifests after 20 weeks’ gestation. It is a leading cause of maternal and fetal morbidity and mortality. Approximately 25% of early-onset preeclampsia cases are severe, and 85% of pregnant women with severe preeclampsia develop multiple organ failure. Stillbirth and early neonatal mortality in women with early-onset preeclampsia are 3%-5% higher than those in cases of late-onset preeclampsia. Birth asphyxia is diagnosed in 100% of newborns. Invasive respiratory support is required in 80% of cases. Every fourth newborn has cardiovascular and central nervous system issues.The analyzed literature demonstrated a possibility of pregnancy prolongation in early-onset preeclampsia using different therapeutic apheresis techniques, which can reduce negative consequences for newborns and mothers.

  • Open Access

    The Possibilities of Thromboelastography in Assessing Safety of Neuraxial Blocks in Gestational Thrombocytopenia (Clinical Study)

    by E. N. Plakhotina, T. N. Belousova, N. B. Kuzina, A. N. Kuzovlev, E. V. Bryantsev

    Gestational thrombocytopenia (GT) is the most common type of thrombocytopenia during pregnancy. Unlike other types of thrombocytopenia, it is not accompanied by dysfunction of the cellular component of hemostasis. Currently, a quantitative decrease in platelets in GT is a contraindication to neuraxial blockades (NAB), which significantly reduces the quality of care in childbirth.The aim of the study is to determine the possibility of safe use of neuraxial blockades in gestational thrombocytopenia. A retrospective prospective study involved 70 patients who were performed delivery, depending on obstetric indications, either conservatively or surgically. The patients were divided into two groups. The main group (group No. 1) included 35 patients with gestational thrombocytopenia. The comparison group (group No. 2) consisted of 35 patients with a platelet content above 150×109/l. A comparative intergroup analysis of indicators of a general blood test, coagulogram, thromboelastography with a test for functional fibrinogen before childbirth and 2 days after delivery. The change in platelet content and its effect on the coagulation status of patients during pregnancy were retrospectively analyzed. A comparative assessment of the volume of blood loss during childbirth and the early postpartum period and the risk of complications of neuraxial blockade in patients with and without gestational thrombocytopenia was carried out.It was found that during gestational thrombocytopenia in the perinatal period, there is no decrease in coagulation potential, assessed by the results of coagulography and thromboelastography at a platelet level above 49×109/l. The investigated indicators of hemostasis did not have significant intergroup differences during pregnancy and childbirth. In the group of patients with gestational thrombocytopenia, the volume of blood loss during labor and the postpartum period did not differ from the group without thrombocytopenia, regardless of the method of delivery. The median blood loss after vaginal delivery in group 1 was 225 ml, in group 2 – 250 ml, with abdominal delivery – 572 ml and 386 ml – respectively. In this study, no complications of neuraxial blockade were observed in any of the groups.The results obtained suggest that in patients with gestational thrombocytopenia, even with a significant decrease in platelet content, it is possible to perform neuraxial blockades during labor, taking into account the clinical picture and the absence of coagulation disorders confirmed by thromboelastography.

  • Open Access

    Differential diagnostic capabilities of calculating the level of neutrophil extracellular traps in the venous blood of pregnant women: a comparative prospective study

    by N. B. Kuzina, E. N. Plakhotina, Artem N. Kuzovlev, T. N. Belousova, E. V. Bryantsev, D. V. Kasina

    Introduction. Severe preeclampsia in early stages can be detected by isolated thrombocytopenia, which makes it difficult to diagnose it in time and carry out the necessary therapeutic measures. As a rule, the diagnosis of severe preeclampsia can be declared with a detailed clinical and laboratory researches, and it increases the risks for the mother and the embryo. However, if there are no clinical symptoms of preeclampsia except of thrombocytopenia, there is a problem of differential diagnosis between thrombocytopenia, which has the same symptoms as preeclampsia and gestational thrombocytopenia, which is a physiological peculiarity and does not require any medical interventions and restrictions. Nowadays there are no screening methods for differential diagnosis of these conditions. Objectives. To estimate the possibilities of determing the level of neutrophil extracellular traps (NETs) during the differential diagnosis of preeclampsia and gestational thrombocytopenia. Materials and methods. The comparative analysis of the level of NETs was carried out in three groups of pregnant women. Group 1 included patients with severe preeclampsia (n = 45), group 2-patients with gestational thrombocytopenia (n = 44) and group 3 consisted of healthy pregnant women (n = 44). Results. The research revealed significant increase in the level of NETs in the group of patients with preeclampsia (15.26 %,) compared with the groups of healthy patients (7.65 %, p = 0.001) and patients with gestational thrombocytopenia (7.04 %, р = 0.002). There were no significant differences in the level of NETs between the groups of healthy patients and patients with gestational thrombocytopenia. Conclusions. A significant increase of the level of NETs among the patients with severe preeclampsia allows us to consider the method of calculating the level of NETs among patients with thrombocytopenia which can be detected after the 20th week of pregnancy, if there are no other laboratory and clinical signs of preeclampsia as a screening method for early diagnosis of this complication.


  • Possibilities to reduce blood loss during organ-preserving surgery in pregnant women with placenta ingrowth

    by I.A. Kulikov, T.N. Belousova, E.N. Plakhotina, D.D. Iskakov, E.R. Milutina

    ЦЕЛЬ ИССЛЕДОВАНИЯ Оценка результатов применения различных методик хирургического гемостаза при оперативном родоразрешении беременных со всеми вариантами врастания плаценты (placenta accreta spectrum — PAS) и выбор оптимальной из них. МАТЕРИАЛ И МЕТОДЫ Прооперированы 173 беременные с диагнозом PAS, которым выполняли 3 различных варианта гемостаза и метропластику. В 1-ю группу (n=32) вошли пациентки, которым после кесарева сечения в дне матки проводили перевязку внутренних подвздошных артерий или маточных сосудов. Во 2-й группе (n=31) осуществляли турникетный гемостаз, а в 3-й группе (n=110) дополняли его баллонной тампонадой влагалища. Изучали объем кровопотери и гемотрансфузии, продолжительность операции и госпитализации — Me [25-й перцентиль; 75-й перцентиль], частоту развития осложнений. РЕЗУЛЬТАТЫ Объем кровопотери в 1, 2 и 3-й группах соответственно составил: 4150 [2764; 5349] мл, 1549 [921,5; 2778,5] мл и 994,5 [730; 1688] мл (p=0,0001). Объем гемотрансфузии эритроцитарной массы в 1-й группе составил: 330 [0; 602,5] мл. В 3-й группе переливаний донорской эритроцитарной массы не было (p=0,0001). Объем гемотрансфузии свежезамороженной плазмы в 1-й группе составил 1069,5 [519,5; 1247,5] мл; во 2-й группе свежезамороженная плазма переливалась небольшому числу пациенток: 0 [0; 600] мл, а в 3-й группе донорская свежезамороженная плазма не потребовалась (pppp=0,035). ЗАКЛЮЧЕНИЕ Использование метода турникетного гемостаза с дополнительной влагалищной тампонадой при оперативном родоразрешении у беременных с PAS сопровождается статистически значимо меньшим объемом кровопотери и гемотрансфузии, меньшей частотой развития осложнений по сравнению с аналогичными показателями при применении метода изолированной перевязки внутренних подвздошных или маточных артерий.

  • Effectiveness of autoplasmodonation in patients with placenta accreta spectrum undergoing organ-sparing surgery

    by E.N. Plakhotina, A.N. Kuzovlev, T.N. Belousova, I.A. Kulikov, K.M. Pavlyutina

    ЦЕЛЬ ИССЛЕДОВАНИЯ Определить безопасность и эффективность применения объемного аутоплазмодонорства при выполнении органосохраняющих операций у пациенток с врастанием плаценты. МАТЕРИАЛ И МЕТОДЫ В проспективное клиническое исследование включены 78 пациенток с диагнозом врастания плаценты. В зависимости от объема предоперационной заготовки аутоплазмы пациентки разделены на 3 группы: пациенткам 1-й группы перед операцией заготовлено до 1000 мл аутоплазмы, 2-й группы — до 2000 мл аутоплазмы, пациенткам 3-й группы (контрольной) заготовка аутоплазмы не проводилась. ЦЕЛЬ Первичная цель исследования — изучить влияние объемного плазмафереза на состояние беременной и плода. С этой целью изучена динамика показателей клеточного состава крови, коагуляционного статуса, состояние маточно-плацентарного и плодового кровотоков в зависимости от объема заготовленной плазмы. Вторичная цель — оценить эффективность интраоперационной трансфузии различных объемов аутоплазмы. Проанализированы объемы интраоперационной кровопотери, инфузионно-трансфузионных сред, использованных для восполнения кровопотери, показатели клеточного состава крови и коагуляции на интраоперационном и послеоперационном этапах у женщин исследуемых групп. Проведен анализ послеоперационных осложнений. Описательная статистика представлена в виде медианы (Me), 25%-го и 75%-го перцентилей (P25; P75), для сравнения применены непараметрические критерии. РЕЗУЛЬТАТЫ В настоящем исследовании не выявлено статистически значимого влияния донорского мембранного плазмафереза, проведенного во II—III триместрах беременности, на показатели клеточного состава крови, коагуляции и показатели маточно-плацентарного и плодового кровотоков. У пациенток группы без аутозаготовок индекс резистентности маточной артерии был значительно выше, чем у пациенток группы аутоплазмодонорства в объеме до 1000 мл после завершения плазмаферезов: 0,54 (0,54; 0,60) и 0,41 (0,38; 0,52) соответственно, p=0,002. Риск развития нарушений маточно-плацентарного кровотока у женщин группы без аутозаготовок оказался значительно выше по сравнению с женщинами группы с заготовкой аутоплазмы до 1000 мл — ОШ 0,09; 95% ДИ [0,01; 0,91]. Показано, что применение 1500—2000 мл аутоплазмы при выполнении органосохраняющих операций по поводу врастания плаценты значительно снижает объем донорских трансфузий, а в 43,8% случаев позволяет полностью отказаться от трансфузии донорской плазмы. Подтверждением высокого риска посттрансфузионных осложнений явилось развитие TRALI-синдрома у пациенток группы контроля. Уровень гемоглобина у женщин 2-й группы перед операцией и перед выпиской из стационара (104 (99; 109) г/л и 77 (72; 89) г/л соответственно) на тех же этапах исследования был статистически значимо ниже, чем у пациенток 1-й группы (112 (107; 122) г/л и 89 (85; 94) г/л) и 3-й группы (112 (105;120) г/л и 99 (83;106) г/л), p=0,008. ЗАКЛЮЧЕНИЕ Безопасной для матери и плода является методика заготовки аутоплазмы методом мембранного плазмафереза до 2000 мл при соблюдении режима заготовок. Использование аутоплазмы в объеме 1500—2000 мл позволяет снизить риски переливания донорской плазмы и осложнений донорских трансфузий. Влияние объемного аутодонорского плазмафереза на показатели уровня гемоглобина и эритроцитов требует дальнейшего изучения.

  • Open Access

    The Choice of Anesthesia During Organ-Saving Operations Concerning Patients With Placenta Accreta Spectrum Disorders

    by E. N. Plakhotina, T. N. Belousova, I. A. Kulikov, R. V. Latyshev, K. M. Pavlyutina

    Placenta accreta (PAS-disorders) is one of the most serious complications of pregnancy, associated with the risk of massive uterine bleeding, massive hemotransfusion and maternal mortality. Peripartum hysterectomy is a common treatment strategy for patients with placenta accreta. Currently, there is a clear trend of changing surgical tactics in favor of organ-saving operations, but there are no studies devoted to anesthesiological support of such operations.The aim of the study is to substantiate an effective and safe method of anaesthesia in organ-saving operations for placenta accreta spectrum disorders.Materia l and methods The study involved 80 patients with a diagnosis of placenta accreta spectrum disorders, confirmed intraoperatively, who underwent organ-saving operations. The patients were randomized depending on the method of anesthesia into 3 groups: general anesthesia, spinal anesthesia with planned conversion to general after fetal extraction and epidural anesthesia with planned conversion to general also after fetal extraction. The comparison of intraoperative hemodynamics, efficiency of tissue perfusion, efficiency of antinociceptive protection at the stages of surgery was performed. A comparative analysis of the volume of blood loss and blood transfusion, time of patients activation in the postoperative period, severity of pain on the first day after surgery, duration of hospital stay before discharge and comparison of the assessment of the newborn according to Apgar score at first and fifth minute after extraction.Conclusion The study shows that the optimal method of anesthesia in organ-saving operations for placenta accreta spectrum disorders is epidural anesthesia with its planned conversion to general anesthesia with an artificial lung ventilation after fetal extraction. Such an approach to anesthesia allows to maintain stable hemodynamic profile with minimal vasopressor support, sufficient heart performance, providing effective tissue perfusion and a high level of antinociceptive protection at the intraoperative stage and reduce the volume of intraoperative blood loss and hemotransfusion. In the current study there were no differences in neonatal outcomes and duration of hospitalization depending on the method of anesthesia. The advantage of epidural anesthesia with its conversion to general anesthesia was earlier activation after surgery and lower intensity of postoperative pain syndrome.


  • Open Access

    The use of neuraxial blockades in obstetric practice for thrombocytopenia

    by E. N. Plakhotina, T. N. Belousova, N. B. Kuzina

    Thrombocytopenia is the second most frequent hematological complica-tion of pregnancy after anemia. Among all thrombocytopenia during pregnancy, the most common is gestational thrombocytopenia. Gestational thrombocytopenia is not accompanied by coagulation disorders, has a minimal risk of bleeding, for both a mother and her fetus. Nevertheless, according to modern concepts, thrombocytopenia is a contraindication for performing obstetric neuroaxial blockades only on the basis of quantitative count of platelets, without taking into account coagulation status. These contraindications are derived from the general surgery and traumatology practice due to the high risk of developing epidural hematoma, but do not take into account the features, including physiological hypercoagulation, of pregnant patients. Refusal of the patient to perform a neuroaxial blockade during delivery on the basis of only counting the number of platelets often leads to an unreasonable increase in the risk / benefit ratio for both the mother and the fetus. Analysis of the research results indicates a change in attitude towards this problem towards a more loyal approach, taking into account the assessment of the coagulative status of a particular patient.